Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Cartalax Anti-Aging Research: Model Comparison

In vitro aged fibroblasts 10–50mcg/mL culture medium, 72-hour exposure Collagen Type I mRNA expression, proliferation rate Chromatin remodelling in COL1A1 gene promoter region 48–72 hours Aged rodent muscle tissue 100mcg subcutaneous, 10-day cycles Cross-secti

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • In vitro aged fibroblasts
  • 10–50mcg/mL culture medium, 72-hour exposure
  • Collagen Type I mRNA expression, proliferation rate
  • Chromatin remodelling in COL1A1 gene promoter region
  • 48–72 hours
  • Aged rodent muscle tissue
  • 100mcg subcutaneous, 10-day cycles
  • Cross-sectional muscle fiber area, satellite cell activation
  • Myogenic transcription factor upregulation (MyoD, Myf5)
  • 14–21 days
  • Human mesenchymal stem cells
  • 20mcg/mL, continuous 14-day culture
  • Differentiation capacity, senescence marker expression (p16, p21)
  • Restoration of multipotency through epigenetic modification
  • 7–14 days
  • Cartilage explant models
  • 50mcg/mL in culture media, 21-day exposure
  • Proteoglycan synthesis, aggrecan gene expression
  • Transcriptional activation of cartilage matrix genes
  • 10–21 days